Condition: Non Small Cell Lung Cancer · Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
The purpose of this project is to evaluate progression-free survival (PFS) of D-1553 Tablet versus Docetaxel Injection in subjects with prior standard therapy failure kirsten rat sarcoma viral oncogene (KRAS) G12C mutation positive locally advanced or metastatic non small cell lung cancer (NSCLC), progression-free survival (PFS) as assessed by the Independent Review Committee (IRC) based on RECIST 1.1 was used as the primary endpoint.
This description comes directly from the study's public registry record.
Shun Lu, Doctor · 13601813062 · shun_lu@hotmail.com
Always discuss trial participation with your own doctor first.
| Anhui Province Hospital | Hefei, Anhui, China | Not Yet Recruiting |
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Xuanwu Hospital Capital Medical University | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Beijing Cancer Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Peking University Third Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Beijing Chest Hospital,Capital Medical University | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The Fifth medical center of Chinese PLA General Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Chongqing Cancer Hospital | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| The Southwest hospital of AMU | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Army Medical Center | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Chongqing University Three Gorges Hospital | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
+ 74 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06300177